Investing
1486 Articles
As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.
Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in…
BioNTech is one of the leading companies in the race to a COVID-19 vaccine. With its shares up more than…
BioNTech and Pfizer are leading the pack of COVID-19 vaccine stocks as this collaboration came out with more positive news…
The number of COVID-19 cases continues to rise, which will only create more demand for coronavirus stocks. 24/7 Wall Street…
Pfizer and BioNTech have progressed in their COVID-19 vaccine effort, according to the FDA. Two of the companies’ four coronavirus…
24/7 Wall St. has identified five defensive stocks that must greatly improve before they are deemed expensive or fully valued…
Pfizer is among the current frontrunners for a COVID-19 vaccine, so why is its stock down 13% year to date?…
24/7 Wall Street has picked out a few of the best and brightest coronavirus stocks that could still see a…
Pfizer and BioNTech have been collaborating to produce a messenger RNA based vaccine for the past few months, and this…
As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks.
As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks. The…
Our top personal finance-related articles today. Your wallet will thank you later.